EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

CES1 and SLC6A2 Genetic Variants As Predictors of Response To Methylphenidate in Autism Spectrum Disorders

Marta H Hernandez iD, Valentin Bote, Alexandre Serra-LLovich, Marc Cendros, Juliana Salazar iD, Conxita Mestres iD, Silvina Guijarro, Aida Alvarez, Cristina Lamborena, Iria Mendez, Bernardo Sanchez, Amaia Hervas und 1 weitere

Pharmacogenomics and Personalized Medicine · 2022-11 · Volume 15 · 951-957

DOI: 10.2147/pgpm.s377210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacogenomics and Personalized Medicine, 2022-11. Verfasst von Marta H Hernandez und 12 weiteren Autor:innen. Beteiligte Einrichtung: Research Laboratory Unit, Fundació Docència i Recerca Mútua Terrassa, Terrassa, Spain. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ADHDASDCES1SLC6A2attention deficit hyperactivity disordersautistic spectrum disordersmethylphenidate

Autor:innen und Institutionen

  • Research Laboratory Unit, Fundació Docència i Recerca Mútua Terrassa, Terrassa, Spain.
  • School of Health Sciences Blanquerna, University Ramon Llull, Barcelona, Spain.
  • Department of Child and Adolescent Psychiatry, Hospital Universitari Mútua Terrassa, Terrassa, Spain.
  • EUGENOMIC Genómica y Farmacogenética, Barcelona, Spain.
  • Translational Medical Oncology Laboratory, Institut de Recerca Biomèdica Sant Pau (IIB-Sant Pau), Barcelona, Spain.

ORCID-Profile: Marta H Hernandez, Juliana Salazar, Conxita Mestres, Maria J Arranz

Zitieren

APA

Hernandez, M. H., Bote, V., Serra-LLovich, A., Cendros, M., Salazar, J., Mestres, C., Guijarro, S., Alvarez, A., Lamborena, C., Mendez, I., Sanchez, B., Hervas, A., & Arranz, M. J. (2022). CES1 and SLC6A2 Genetic Variants As Predictors of Response To Methylphenidate in Autism Spectrum Disorders. Pharmacogenomics and Personalized Medicine, Volume 15, 951-957. https://doi.org/10.2147/pgpm.s377210

Vancouver

Hernandez MH, Bote V, Serra-LLovich A, Cendros M, Salazar J, Mestres C, et al. CES1 and SLC6A2 Genetic Variants As Predictors of Response To Methylphenidate in Autism Spectrum Disorders. Pharmacogenomics and Personalized Medicine. 2022;Volume 15:951-957. doi:10.2147/pgpm.s377210

BibTeX
@article{Hernandez2022,
  author = {Hernandez, Marta H and Bote, Valentin and Serra-LLovich, Alexandre and Cendros, Marc and Salazar, Juliana and Mestres, Conxita and Guijarro, Silvina and Alvarez, Aida and Lamborena, Cristina and Mendez, Iria and Sanchez, Bernardo and Hervas, Amaia and Arranz, Maria J},
  title = {CES1 and SLC6A2 Genetic Variants As Predictors of Response To Methylphenidate in Autism Spectrum Disorders},
  journal = {Pharmacogenomics and Personalized Medicine},
  year = {2022},
  volume = {Volume 15},
  pages = {951--957},
  doi = {10.2147/pgpm.s377210}
}
Kostenlos starten →